ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 701

Extension Of Cardiac Damage Through The Delayed Enhancement Of Cardiac Magnetic Resonance: Predictive Value Of a Combined Approach Based On Clinical and Laboratory Findings, EKG-Holter and Cardiac Magnetic Resonance

Silvia Laura Bosello1, Giacomo De Luca1, Agostino Meduri2, Giorgia Berardi1, Manuela Rucco1, Giovanni Canestrari1, Federico Parisi1 and Gianfranco Ferraccioli1, 1Division of Rheumatology, Institute of Rheumatology and Affine Sciences, Catholic University of the Sacred Heart, Rome, Italy, 2INSTITUTE OF RADIOLOGY - Catholic University of the Sacred Heart, ROME, Italy

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Heart disease, Magnetic resonance imaging (MRI) and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s - Clinical Aspects and Therapeutics I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Cardiac involvement is a relevant prognostic determinant in Systemic Sclerosis (SSc), but the diagnosis is often delayed due to the lack of a specific diagnostic algorithm.

Recent studies, screening the hearts of subclinical consecutive SSc patients by delayed enhancement (DE) – cardiac magnetic risonance (CMR), found that 21-66% had midwall DE-CMR. We studied the hearts of symptomatic SSc patients through CMR and we evaluated the role of a combined approach, based on evaluation of clinical symptoms, laboratory findings, EKG-holter and CMR, to characterize cardiac involvement in SSc-patients. 

Methods:

Thirty-six SSc-patients with symptoms of cardiac involvement (dyspnea, palpitation) and/or signs of cardiac failure and elevation of cardiac enzymes (MB-CK and/or troponin T) underwent EKG-holter and cardiac magnetic resonance (CMR).  Median follow-up was 24±0.2 months. 

Results:

Major EKG-holter modifications were present in 30.6% of patients. CMR study demonstrated T2 hyperintensity in 3 patients while none of the patients presented early gadolinium enhancement and 18 (50.0%) patients presented late gadolinium enhancement (LGE). We identified 3 different patterns of distribution of LGE: subepicardial, midwall and subedocardial. Eleven patients presented a single pattern of distribution, while 7 patients (38.8%) presented more than one: 61.1% of patients presented a midwall distribution of LGE, 33.3% of patients presented a subepicardial LGE with a linear distribution pattern and 22.2% presented a subendocardial LGE distribution. 38% of patients showed hypokinetic area and only one patient an akinetic area. The mean EF of left ventricle was 61.7±10.8%, and of right ventricle was 58.1±10.3%.  Hypokinetic and akinetic area corresponded with the LGE area. The extension of LGE on CMR was evaluated according to a standardized left-ventricular segmentation. When CMR demonstrated a DE, the mean number of involved cardiac segments was 3.3±2.7. Segment number 9 was involved in 44.4% of the patients, followed by segments number 3 and 5 (38.9%) and by segment 2 (27.8%). Patients with major abnormalities on EKG-holter presented a higher number of involved myocardial segments on CMR (3.7±2.3) with respect to the patients without EKG-abnormalities (0.9±1.4), (p=0.012). After a mean follow-up of 24±0.2 months, 4 patients (16%) died for arrhythmias or heart failure.

All patients, who died at follow-up, had severe dyspnea, elevated cardiac enzymes, myosytis,  major EKG-holter abnormalities, reduction of EF and LGE on CMR at baseline; 75% of patients who died had a subendocardial distribution pattern of LGE on CMR.

Conclusion:

Our study suggests that a combined approach, based on clinical presentation, laboratory findings, EKG-holter examination and study of distribution of LGE on CMR, is useful to characterize the extension of myocardial damage and to identify patients with a poor outcome related to heart involvement in SSc.


Disclosure:

S. L. Bosello,
None;

G. De Luca,
None;

A. Meduri,
None;

G. Berardi,
None;

M. Rucco,
None;

G. Canestrari,
None;

F. Parisi,
None;

G. Ferraccioli,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/extension-of-cardiac-damage-through-the-delayed-enhancement-of-cardiac-magnetic-resonance-predictive-value-of-a-combined-approach-based-on-clinical-and-laboratory-findings-ekg-holter-and-cardiac-mag/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology